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Calcium Channel and NMDA Receptor Activities
Differentially Regulate Nuclear C/EBP Levels
to Control Neuronal Survival
NMDA receptors and appears to contribute to glutamate
excitotoxicity (Ruiz et al., 2000; Guo et al., 2001a).
Differential calcium effects may arise, in part, from
differences in the subcellular distribution of calcium-
dependent enzymes. For instance, calcium influx via
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Summary At the nuclear level, IGF-1 and L channel activity are
effective at activating survival-supporting transcription
Insulin-like growth factor-1 (IGF-1) promotes the sur- factors such as CREB and MEF2 (Misra et al., 1994;
vival of cerebellar granule neurons by enhancing cal- Bonni et al., 1999; Mao et al., 1999; Riccio et al., 1999).
cium influx through L-type calcium channels, whereas The mechanism requires calmodulin (CaM), which asso-
NMDA receptor-mediated calcium influx can lead to ciates with neuronal L channels (Peterson et al., 1999).
excitotoxic death. Here we demonstrate that L and Calcium influx leads to CaM activation, which, via the
NMDA receptor channel activities differentially regu- MAPK pathway, elevates pCREB levels (Dolmetsch et
late the transcription factor C/EBP to control neu- al., 2001). Additionally, L channel activity can lead to
ronal survival. Specifically, we show that L channel- nuclear translocation of CaM and elevated nuclear cal-
dependent calcium influx results in increased CaMKIV cium levels that, in turn, stimulate Ca2/CaM-dependent
activity, which acts to decrease nuclear C/EBP lev- protein kinase-IV (CaMKIV) to phosphorylate CREB (Deis-
els. Conversely, NMDA receptor-mediated influx rap- seroth et al., 1998; Chawla et al., 1998; Hu et al., 1999).
idly elevates nuclear C/EBP and induces excitotoxic Other calcium-dependent transcription factors that
death via activation of the calcium-dependent phos- may play significant roles in survival include the CCAAT
phatase, calcineurin. Moderate levels of AMPA recep- enhancer binding proteins (C/EBPs). To date, six genes
tor activity stimulate L channels to improve survival, encoding a minimum of eight isoforms have been identi-
whereas higher levels stimulate NMDA receptors and fied. C/EBP proteins function as dimers and contain a
reduce neuronal survival, suggesting differential syn- transactivating domain, a DNA binding region, and a
aptic effects. Finally, N-type calcium channel activity leucine zipper (Olive et al., 1996). They are regulated
reduces survival, potentially by increasing glutamate transcriptionally, posttranslationally, and by the ability
release. Together, these results show that the L-type to hetero- as well as homodimerize (Niehof et al., 2001);
calcium channel-dependent survival and NMDA re- at least some C/EBPs can heterodimerize to form re-
ceptor death pathways converge to regulate nuclear pressors (Descombes and Schibler, 1991). C/EBPs are
C/EBP levels, which appears to be pivotal in these also being increasingly associated with survival and dif-
mechanisms. ferentiation processes (Sterneck and Johnson, 1998;
Cortes-Canteli et al., 2002; Ramji and Foka, 2002; Zhu
et al., 2002). Interestingly, the full-length  subtype isIntroduction
regulated by CaMKIV (Yukawa et al., 1998), as well as
PI3K and Akt (Guo et al., 2001b; Piwien-Pilipuk et al.,In neurons, calcium influx can serve as both a signal
2001), both of which are essential for IGF-1/L channelpromoting survival as well as in some instances promot-
potentiation-induced survival (Blair and Marshall, 1997;ing cell death. Survival is promoted by insulin-like
Blair et al., 1999).
growth factor-1 (IGF-1) and L channel-mediated calcium
Here, we investigate the downstream signaling re-
influx (Galli et al., 1995; Dudek et al., 1997). L channel
sponsible for L channel-mediated neuronal survival and
activity is directly controlled by depolarization, but also potential antagonistic actions of NMDA receptor activ-
is enhanced by IGF-1 through a pathway that requires ity. We focused on the potential roles of C/EBP and
PI 3-kinase (PI3K), Akt, and ultimately src-dependent CaMKIV in IGF-1- and L channel-mediated survival, and
phosphorylation of the channel (Blair and Marshall, we found a novel mechanism. IGF-1, in an L channel-
1997; Blair et al., 1999; Bence-Hanulec et al., 2000). dependent manner, rapidly stimulates CaMKIV activity
Nonetheless, calcium does not invariably act as a pro- to promote neuronal survival by reducing nuclear levels
survival factor. Calcineurin, a calcium- and CaM-depen- of C/EBP. Conversely, loss of growth factor support or
dent serine/threonine phosphatase, can be activated by strongly stimulating NMDA receptors rapidly increased
nuclear import of C/EBP and induced subsequent cell
death.*Correspondence: john_marshall@brown.edu
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IGF-1- and L Channel-Dependent Survival
Require CaMKIV
We next tested the potential role of CaMKIV in IGF-1-
and L-mediated survival. Cultured cerebellar granule
neurons were transiently cotransfected with cDNAs en-
coding a catalytically inactive CaMKIV (dn-CaMKIV;
Chatila et al., 1996) and, to identify transfected neurons,
GFP. After 1 day, survival of neurons overexpressing
dn-CaMKIV was compared with that of untransfected
neurons in the same cultures and that in sister cultures
transfected with wild-type (wt) CaMKIV. Cells were con-
firmed as neuronal by immunolabeling with Tuj1, an anti-
body against neuron-specific class III -tubulin (see
Supplemental Figure S1 at http://www.neuron.org/cgi/
content/full/39/4/625/DC1). We found that overexpress-
ing dn-CaMKIV prevented survival (Figures 2A, 2B, and
2F), suggesting that CaMKIV activity may be an absolute
requirement. In contrast, overexpressing wt-CaMKIVFigure 1. IGF-1 Rapidly Stimulates Both CaMKII and -IV, but Only
had only modest effects when IGF-1 was present at aCaMKIV Activity Remains Elevated for Extended Times
relatively high level (50 ng/ml; Figure 2F, SupplementalTime course of IGF-1 stimulation revealed a small, transient increase
Figures S2A–S2C). To block endogenous and overex-in CaMKII activity (circles), but a large and longer duration increase
pressed wt-CaMK activity acutely, neurons were treatedin CaMKIV activity (squares). Although both activities increased
within 2 min, the small change in CaMKII activity rapidly returned with KN62 or its vehicle, then briefly stimulated with
to baseline, while CaMKIV activity remained elevated for 2 hr. IGF-1 in the presence or absence of calcium channel
Squares with vertical stripes: blocking L channel activity with 5 M inhibitors. We found that acute inhibition of CaMKs fully
nimodipine largely blocked the IGF-1-stimulated increase in CaMKIV
blocked the IGF-1-induced increase in survival and alsoactivity. Square with horizontal stripes: the general CaMK inhibitor,
appeared to block basal L channel-dependent survival,KN62 (10 M), also blocked the increase in CaMKIV activity. Sister
suggesting that L channel and CaMKIV activities uti-cultures of granule neurons were stimulated with IGF-1 (50 ng/ml)
for 2 min–4 hr, then CaMKII and -IV were specifically immunoprecipi- lize the same molecular signaling pathways (Figures 2G
tated and their activities assessed in vitro. Activity levels following and 7).
IGF-1 stimulation were normalized to the baseline activities ob- Significantly, constitutively active (ca) CaMKIV strongly
served in the absence of IGF-1. For CaMKIV, data are means  promoted neuronal survival in the absence of IGF-1
SEMs from four experiments; n  2 experiments for CaMKII.
(Figures 2C–2F), while a cytoplasmically targeted consti-
tutively active CaMKII had no effect (Figure 2F). Over-
expresssing ca-CaMK kinase (CaMKK), a calcium-
dependent enzyme required for CaMKIV activation, also
Results
increased survival (Figure 2F). We further tested if ca-
or wt-CaMKIV-dependent survival required L channel
IGF-1 Rapidly Stimulates Both CaMKII and -IV, activity: survival of untransfected, ca-CaMKIV-trans-
but Only CaMKIV Activity Remains Elevated fected, and wt-CaMKIV-transfected neurons was95%
IGF-1 and CaMK activity have been separately shown in the presence of IGF-1 but was reduced to 65%
to improve neuronal survival, but it was unknown if IGF-1 by the L channel blocker nimodipine (Figures 2D–2G,
could activate CaMKs. We therefore tested this and Supplemental Figures S2B and S2C). Indistinguishable
assessed dependence on L channel activity. Sister cul- results were obtained when the nonspecific blocker cad-
tures of cerebellar granule neurons were exposed to mium (Cd2) was used the during brief (1 min) exposure
IGF-1 (50 ng/ml) for up to 4 hr, and CaMKII and -IV to IGF-1 (Figure 3A). Interestingly, extended Cd2-block
specifically immunoprecipitated. Kinase activities were improved survival, suggesting that extended block of
then assayed in vitro by determining 32P-incorporation other calcium channel subtypes might exert prosurvival
into specific substrates (Yoshida et al., 2000). Both activ- effects and leading us to test N channel inhibition (see
ities increased within 2 min, but the peak elevation of Figure 6B).
CaMKIV activity was4-fold greater and of longer dura- We also found that increasing CaMKIV levels shifted
tion than that of CaMKII (Figure 1; n  4 independent the sensitivity to IGF-1- and L channel-mediated sur-
experiments). Maximal CaMKIV stimulation occurred at vival. Physiological levels of IGF-1 in the CNS are typi-
10 min. Comparable results were obtained using cally defined as the levels detected in cerebrospinal
whole-cell extracts and a CaMKIV-specific substrate fluid. Nonetheless, the levels directly experienced by
(n  2 independent experiments). neurons and their fluctuation over time are unknown.
L channel activity was necessary. When IGF-1 was We therefore determined the dose responsiveness of
added in the presence of nimodipine and CaMKIV activ- survival to IGF-1, if transient stimulation was sufficient
ity assessed after a 10 min stimulation, the increase was and if responsiveness was affected by CaMKIV levels.
largely, although not completely, blocked (Figure 1). As Neurons were transfected with wt-CaMKIV and exposed
an internal control, the general CaMK inhibitor, KN62, briefly (1 min) to increasing IGF-1 concentrations. Cul-
was also tested; it, but not its vehicle, fully blocked the tures were then maintained for 1 day in unsupplemented
test medium. We found that moderate-high levels ofIGF-1-induced increase (Figure 1).
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Figure 2. Overexpressing Inactive CaMKIV Abolishes Granule Neuron Survival, while Overexpressing Constitutively Active CaMKIV Mimics
IGF-1
(A–E) After 1 day in the indicated test media, all neurons were stained with propidium iodide (PI) to reveal DNA (lower), and transfected neurons
were identified by GFP fluorescence (upper). Healthy transfectants having dispersed chromatin are indicated by open arrowheads; apoptotic
transfectants having bright, condensed chromatin, closed arrowheads.
(A and B) Neurons expressing inactive (dn) CaMKIV are apoptotic, even though in IGF-1-containing media, the surrounding untransfected
neurons are healthy.
(C) In the absence of exogenous support factors, neurons transfected with a constitutively active (ca) CaMKIV thrive, while most untransfected
ones do not. Immunocytochemical analysis confirmed that the heterologous CaMKIV localized correctly to the nucleus (see Supplemental
Figure S2D).
(D) In IGF-1, untransfected as well as ca-CaMKIV-transfected neurons survive.
(E) When L channel activity is inhibited (nim), survival in both ca-CaMKIV-transfectants and nontransfectants is reduced, indicating a requirement
for calcium influx.
(F) CaMKIV is required for neuronal survival. Overexpressing dominant-negative CaMKIV eliminates survival, even in the presence of IGF-1.
Conversely, constitutively active CaMKIV and CaMKK induce full survival by themselves (No add), but only if L channels are active; when L
channels are inhibited (IGF-1nim, nim), survival drops to levels similar to those seen in untransfected neurons and wild-type CaMKIV
transfectants. Interestingly, constitutively active CaMKII failed to improve survival. IGF-1, 50 ng/ml; nimodipine (nim), 5 M. Open bars, survival
of transfected neurons. Narrow closed bars, survival of untransfected neurons in the same cultures. Data are meansSEMs from 6 independent
experiments. All detectable transfectants were counted; n/bar  700 neurons (range, 594–853). For nontransfectants, all nongreen neurons
in 4 randomly chosen fields/dish were counted; n/bar3500 neurons (range, 2887–4416). Asterisk indicates when the survival of transfectants
was significantly different from untransfected neurons in the identical test condition (p  0.005, Student’s t test); double asterisk indicates
the cases when survival was slightly different between transfectants and nontransfectants in a given test condition (p  0.025).
(G) The general CaMK inhibitor, KN62, eliminates IGF-1-induced survival in neurons expressing endogenous and elevated wt-CaMKIV levels.
Open and closed bars, as in (F). Few neurons survived 1 day after transient exposure to KN62 (10 M for 2 hr); the level was indistinguishable
from that seen when L channels were blocked in the absence of IGF-1 (see F, 33%  2%). After KN62 pretreatment, neither IGF-1 (50 ng/ml,
1 min) nor L channel inhibition (5 M nimodipine or 100 M Cd2) had any effect. Conversely, IGF-1 in the KN62 vehicle (0.1% DMSO) produced
nearly complete survival, and vehicle alone produced a level of survival similar to that observed in test media alone (i.e., no IGF-1 but also
no L channel block; see F, 41%  2%). Data are means  SEMs from 4 experiments.
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Figure 3. Overexpressing Wild-Type CaMKIV Reduces the Requirement for IGF-1, but Maintains an L Channel-Dependent Component
Solid symbols, transfected neurons; open symbols, sister nontransfectants. Values are means  SEMs.
(A) A brief pulse of IGF-1 promotes neuronal survival: dose-response analysis shows that neurons with elevated wt-CaMKIV levels need less
IGF-1 to survive, but retain a requirement for calcium influx. IGF-1 was applied for 1 min, then cultures were rinsed and placed in 0-serum
medium for 24 hr. L channel activity was inhibited during the IGF-1 stimulation with either nimodipine (5 M) or Cd2 (100 M). No differences
between brief Cd2- and nimodipine-block were detectable at any IGF-1 concentration (p  0.4, Student’s t test). n/test condition  450
wt-transfected neurons (range, 433–473) and 2700 nontransfectants (range, 2387–3182) from 3 independent experiments.
(B) Overexpressing wt-CaMKIV allows very low concentrations of the L channel agonist, (-)-BayK8644 (1 day treatment), to promote survival.
n/test concentration  500 wt-transfected neurons (range, 373–645) and 3100 nontransfectants (range, 2638–3605) from 3 independent
experiments.
IGF-1 (10–100 ng/ml) increased survival of both transfec- 1% (wt-CaMKIV transfectants and nontransfectants, re-
spectively). Interestingly, neurons depolarized for 10 mintants and nontransfectants almost to the levels obtained
with a 24 hr application, but that at very low concentra- survived less well (62%  2% and 61%  1%, p 
0.001) than those depolarized for 1 min, again implyingtions (0.01–0.1 ng/ml), wt-CaMKIV-overexpressing neu-
rons survived much better (Figure 3A). This suggests that calcium levels need to be optimized. Together, the
results indicate that increasing CaMKIV levels primesthat the requirement for IGF-1 can be reduced or partially
bypassed by increasing CaMKIV. We further found that the survival mechanism, reducing but not eliminating a
requirement for moderate calcium influx.at all IGF-1 concentrations, blocking L channel activity
reduced survival (Figure 3A), implying that L channel-
mediated calcium influx remains required and that addi- Inhibiting C/EBP Activity Enhances Neuronal
Survival in the Absence of IGF-1tional survival processes are calcium dependent.
L channel activity is also neuroprotective in the ab- C/EBPs are calcium- and CaMK-regulated transcription
factors recently implicated in the survival of a variety ofsence of growth factor support. We therefore tested if
increasing CaMKIV levels would affect survival pro- cell types, but not directly tested in neurons. To establish
if they contribute to the antiapoptotic effects of IGF-1moted by the L channel agonist, (-)-BayK8644 (Figure
3B). As previously shown (Blair et al., 1999), optimal or L channel activity in primary neurons, we utilized a
dominant-negative C/EBP (dn-C/EBP) known to inhibitconcentrations of (-)-BayK8644 were strongly but in-
completely neuroprotective. In its absence, survival of the DNA binding activity of all C/EBPs in vivo (Olive
et al., 1996). Cultured granule neurons were transientlyboth transfectants and nontransfectants was poor. In
high concentrations, survival decreased below that of cotransfected with cDNAs encoding dn-C/EBP plus
GFP. After 1 day, survival of transfectants was assessedthe unsupplemented test medium, consistent with the
idea that excessive calcium causes cell death. However, using either propidium iodide labeling or the TUNEL
assay for nicked DNA. Intriguingly, we found that generallow (1 M) but nonzero concentrations were much
more neuroprotective for wt-CaMKIV-overexpressing inhibition of C/EBP activity dramatically elevated sur-
vival (Figures 4A and 4F): in serum-free test medium,neurons than their untransfected sisters.
Similarly, depolarization-induced survival was better 84%  2% of the dn-C/EBP-transfected neurons sur-
vived, as compared to 44%  2% among the non-in neurons expressing higher levels of wt-CaMKIV and
was fully inhibited by simultaneous treatment with L transfectants in the same culture. Wild-type was also
tested.channel blockers. Neurons were exposed for 1 min to
90 mM KCl (expected to drive the membrane potential
to 10 mV), rinsed, and returned to unsupplemented Specific Inhibition of C/EBP Mimics
IGF-1-Induced Survival and Reduces NMDAtest medium for 24 hr. We found that survival was 73%
2% in wt-CaMKIV-overexpressing neurons, but only Receptor-Mediated Death
The  isoform of C/EBP was of particular interest since66%  1% in untransfected neurons (p  0.001, Stu-
dent’s t test). In addition, the improved survival required its activity can be controlled via PI3K and Akt (Guo et
al., 2001b; Piwien-Pilipuk et al., 2001), known compo-L channel-mediated influx: in 90 mM KCl plus nimodipine
(5 M), survival was reduced to 43%  1% and 42%  nents of IGF-1-dependent neuroprotection. To test this,
L Channels and NMDA Receptors Regulate C/EBP
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C/EBP levels were manipulated by several approaches. independent experiments). In contrast, nuclear levels
remained low in neurons maintained in serum-free me-First, we increased them by overexpressing wild-type
dia supplemented with IGF-1; at 1 hr, the relativeC/EBP and found that survival significantly decreased
change, 1.0 0.1-fold, was not detectably different from(30%  2%; Figures 4A and 4F).
1.0 (Figure 5A, panel a1; n  5 independent experi-To confirm the involvement of C/EBP, its levels were
ments). After 2 hr in IGF-1, levels even appeared tospecifically reduced using both antisense and siRNA
decrease (0.6 0.3). Moreover, IGF-1 appears to reverseapproaches (Taubenfeld et al., 2001a; Krichevsky and
the effects of serum withdrawal, slightly decreasing nu-Kosik, 2002). As controls for any nonspecific effects of
clear C/EBP levels as soon as 15 min after additiontransfection, sister cultures were treated with either a
and strongly decreasing them by 1 hr (0.7  0.1; Figuresequence-scrambled antisense C/EBP oligodeoxy-
5B). Dose dependence was also observed (Figure 5A,nucleotide (ODN) or an siRNA that did not affect nuclear
panel a2; n  3 independent experiments): althoughC/EBP levels. Cell counts were performed after 1 day
nuclear C/EBP levels were high after 2 hr in unsupple-in serum-free unsupplemented test medium, treating all
mented medium, levels in sister cultures exposed toneurons as probable transfectants (see Experimental
minimal IGF-1 concentrations were low (0.5 ng/ml,Procedures). Survival in both C/EBP antisense and
39%  2% relative to no IGF-1), and increasing IGF-1siRNA was high: 89% 1% and 90% 3%, respectively
further reduced nuclear levels (5 ng/ml, 24%  4%; 50(Figures 4B, 4D, and 4G), values indistinguishable from
ng/ml, 18% 4%; 500 ng/ml, 11% 5%). Experimentalthose obtained upon IGF-1 treatment of nontransfected
controls included assessing CREB; as expected, IGF-1neurons (91%  2%, Figure 4F). Conversely, survival in
increased its phosphorylation (data not shown). As con-the presence of the sequence-scrambled ODN or non-
trols for the subcellular fractionation procedure, bothblocking siRNA was 44% 3% and 37% 3% (Figures
nuclear and cytoplasmic fractions were assayed for the4C, 4E, and 4G), similar to untreated neurons in basic
presence of unique markers: the transcription factor,test medium (43%  2%, Figure 4F) and showing that
c-jun, was found only in the nuclear fraction, while thethe improved survival was directly dependent on inhib-
nonnuclear marker, the mitochondrial enzyme GAPDH,iting the C/EBP subtype.
was excluded (Supplemental Figure S3B).Both antisense and siRNA inhibition of C/EBP antag-
The rapid effects did not appear to involve degrada-onized NMDA receptor-mediated death. When neurons
tion or de novo synthesis. With or without IGF-1, levelswere continuously exposed to high levels of NMDA (300
were, respectively, 0.8  0.2 or 1.0  0.1 at 30 min andM  1 M glycine), a substantial fraction of the anti-
0.9  0.2 or 1.1  0.1 at 2 hr (Supplemental Figure S3Csense and siRNA transfectants survived (69%  5%
at http://www.neuron.org/cgi/content/full/39/4/625/and 67%  3%, respectively; Figures 4B, 4D, and 4G).
DC1; n  2 independent experiments). When assayedHowever, almost no neurons treated with the control
immunocytochemically and biochemically using transla-ODN or nonblocking siRNA lived (3%  1%, 4%  2%;
tional or transcriptional inhibitors (cycloheximide, acti-Figures 4C, 4E, and 4G). Significantly, antisense treat-
nomycin D), levels were not significantly higher than inment may be able to rescue severely traumatized neu-
IGF-1 alone (Supplemental Figure S3D), suggesting thatrons. When pretreated with NMDA prior to transfection
C/EBP was being translocated between subcellularand then maintained in NMDA, essentially all control
compartments. In addition, treatment with either anti-neurons died (3%  2%), but 22%  6% of the anti-
sense ODN or siRNA was able to keep nuclear C/EBPsense-treated neurons survived.
levels low in neurons maintained 1 day in 0-serum (Fig-
ure 5C; n  3 independent experiments, ODN; n  4
Antagonistic Regulation of Nuclear C/EBP independent experiments, siRNA).
Levels and Survival The IGF-1 effect was linked through L channel and
The survival data implies that increasing C/EBP ex- CaMKIV activities. Inhibiting L channels during IGF-1
pression reduces survival. To establish if this was due treatment led to a 2-fold increase in nuclear C/EBP
to increased availability of the transcription factor, nu- levels (Figure 5A, panel a1; n  10 independent experi-
clear C/EBP levels were assayed biochemically and ments). Inhibiting L channel activity also increased nu-
immunocytochemically. Briefly, we found that nuclear clear levels in neurons overexpressing wild-type
levels were high in the absence of growth factors but C/EBP. However, any IGF-1 effects mediated by L
low in the presence of IGF-1, although blocking either channel potentiation rely on spontaneous electrical ac-
CaMK or L channel activities increased them (Figures tivity to open the channels. Consequently, we tested if
5A and 5B; Supplemental Figure S3A at http://www. directly activating L channels with moderate depolariza-
neuron.org/cgi/content/full/39/4/625/DC1). Similarly, tion (25 mM KCl, predicted to drive the membrane poten-
NMDA receptor activity also increased them, an effect tial to45 mV) would also maintain low nuclear C/EBP
that antisense C/EBPblocked (Figures 5A and 5D; Sup- levels. Neurons depolarized in the absence of growth
plemental Figures S4 and S5). factor support did have low C/EBP levels, but not if L
The increase in nuclear C/EBP levels observed upon channel activity was blocked with nimodipine (Figure
growth factor deprivation was very rapid (Figure 5B). 5A, panel c; n  3 independent experiments). Similarly,
Effects were detectable within 1 min and increased with the general CaMK inhibitor, KN62 (10 M), blocked the
time: the fold-changes at 1 min, 5 min, and 1 hr were, ability of IGF-1 to maintain low nuclear levels: levels
respectively, 1.7 0.4, 2.8 0.9, and 4.0 0.9 (mean increased 3.0  0.3-fold within 1 hr (Figure 5A, panel
SEM, calculated relative to the 1.0 level observed in full a1; n 4 independent experiments). Assessed immuno-
serum media, quantified by Western blot analyses and cytochemically, overexpressing a dominant-negative
CaMKIV and treatment with KN62 both increased nu-scanning densitometry of subcellular fractions; n  7
Neuron
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Figure 4. Role of C/EBP in Neuronal Survival/Death Pathways
(A) General inhibition of C/EBPs enhances neuronal survival while overexpressing C/EBP reduces it. Granule neurons were cotransfected
with GFP and either a dominant-negative C/EBP (dn-C/EBP) that inhibits DNA binding activity of all known C/EBPs or full-length wild-type
C/EBP. Survival was assessed after 1 day in 0-serum test medium. Top, transfectants identified by GFP fluorescence. Bottom, all neurons
in the same field labeled with propidium iodide (PI) or TUNEL to reveal DNA; closed arrowheads, apoptotic transfectants; open arrowheads,
healthy cells. Left panels: in the absence of growth factor support, dn-C/EBP-expressing neurons survived much better than untransfected
neurons in the same culture when assessed by PI staining. When assessed using the TUNEL assay for damaged DNA, dn-C/EBP-expressing
neurons were TUNEL negative, even though many surrounding untransfected neurons were TUNEL positive. Center panels: L channel inhibition
reduced, but did not eliminate, survival of dn-C/EBP-expressing neurons. Right panels: in sister cultures, neurons overexpressing wild-type
C/EBP survived poorly, having condensed chromatin (PI) and being TUNEL positive.
(B and D) Specific inhibition of C/EBP with an antisense oligodeoxynucleotide (ODN, B) or siRNA (D) enhances neuronal survival in the
absence of growth factor support and opposes NMDA-induced excitotoxity. Left, antisense- and siRNA-treated neurons survived well. Right,
continuous NMDA treatment induced only moderate damage.
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clear C/EBP levels (Figure 5A, panels d2 and d3), while (p  0.001; n  2 independent experiments), implying
that translocation is an important mechanism by whichlevels fell in neurons overexpressing a constitutively ac-
tive CaMKIV (Figure 5A, panel d1; n  6 independent IGF-1 regulates C/EBP to control survival (Figure 7).
experiments). Analysis of confocal Z-sections verified
that, in the presence of IGF-1, L channel activity, and AMPA Receptors Can Activate L Channels
and Promote L Channel-Mediated SurvivalC/EBP-antisense, C/EBP was largely excluded from
nuclei, while serum deprivation and L channel block IGF-1 potentiates but does not directly activate voltage-
sensitive L channels. We therefore attempted to deter-increased nuclear levels (Figure 5A, panel b, Supple-
mental Figures S3A and S5B). mine the means by which L channel activity is stimulated
and found that AMPA receptors appear to play a pivotalWe also found that NMDA treatment increased nu-
clear levels and that the NMDA-induced nuclear localiza- role, increasing L channel activity to promote survival
and NMDA receptor activity to increase excitotoxiction required the calcium-dependent phosphatase cal-
cineurin (Figure 5A, panel a1, Supplemental Figures S4A death.
Low concentrations of the AMPA receptor agonist,and S4B at http://www.neuron.org/cgi/content/full/39/
4/625/DC1). Deltamethrin (1 M), a specific inhibitor, kainate, significantly elevated L channel-mediated sur-
vival (Figure 6A). Increasing kainate concentrationsblocked the NMDA-dependent increase in nuclear
C/EBP (n  6 independent experiments) and simulta- (0–100 M) were tested in combination with 0.8 M
(-)-BayK8644, a concentration of the L channel modula-neously increased survival (72%  4%, p  0.001 when
compared with 15%  2% for NMDA alone; n  3 inde- tor that produces submaximal survival (60%, Blair et
al., 1999). We found that the lower kainate doses im-pendent experiments). Deltamethrin also reduced nu-
clear levels in neurons maintained in 0-serum test me- proved survival, but that the improvement was entirely
reversed by L channel blockade. Moreover, when thedium (Supplemental Figure S4C). Moreover, IGF-1
partially reversed the NMDA-induced rise in nuclear NMDA receptor inhibitor APV was included with
BayK864410 M kainate, nearly all neurons survived.C/EBP levels (Supplemental Figure S4D; n  6 inde-
pendent experiments) and, in parallel, raised survival Consistent results were obtained with kainate alone or
direct NMDA receptor stimulation (Figure 6A). Com-(66% 3%, p 0.001; n 3 independent experiments).
Significantly, IGF-1 could reverse the nuclear localiza- pared to “No add,” 10 M kainate elevated survival in
an L channel-dependent manner, but 100 M kainatetion induced by serum deprivation and NMDA treatment
(Figures 5B and 5D). L channel activity was required. reduced it. When NMDA receptor activity was directly
stimulated (300 M NMDA  1 M glycine for 30 min),When inhibited, nuclear C/EBP levels rose (Supple-
mental Figure S4E) and survival fell (40%  3%; n  4 survival after 1 day was poor and reduced further by
coaddition of 100 M kainate. However, coaddition ofindependent experiments). This suggests that in terms
of survival, NMDA receptor and L channel activities act 10 M kainate significantly enhanced survival, again in
an L channel-dependent manner. This suggests that theantagonistically. Since neurotransmission occurs spon-
taneously in these cultures (Mellor et al., 1998), we overriding effect of strongly activating AMPA receptors
is to stimulate the NMDA receptor/prodeath pathways,tested blockade of endogeneous NMDA receptor activ-
ity. The NMDA receptor inhibitor, APV, which alone pro- while moderate activation stimulates L channels to pro-
mote survival.motes survival (see Figure 6B), was able to keep nuclear
levels low (Figure 5A, panel a1, Supplemental Figure Testing combinations of specific antagonists con-
firmed the dual role of AMPA receptor activity (FigureS4F), as did N channel inhibition (Supplemental Figure
S4G), suggesting that the rise observed in unsupple- 6B; “No IGF-1”). After 1 day without IGF-1, survival was
poor (“No add”), and blocking basal L channel activitymented test medium was due, at least in part, to excit-
atory neurotransmission. Strikingly, the ability to reverse (“nim”) produced a 10% further decrease. In contrast,
inhibiting NMDA receptors (“APV”) radically improvedthe effects of growth factor withdrawal and NMDA also
required the nuclear transport protein, CRM1, also survival, but simultaneous L channel block (“APVnim”)
again produced a 10% decrease, implying thatcalled exportin-1. Inhibition by leptomycin B (Henderson
and Eleftheriou, 2000) blocked the reversal (Figure 5D; blocking NMDA receptor activity did not affect L channel
activity. No effect of kainate receptor activity was de-n  3 independent experiments). Blocking C/EBP ex-
port also kept survival low: 22%  6% after 1 day in tected. Blocking both kainate and AMPA receptors with
CNQX or high concentrations of NBQX (100 M) wasleptomycinIGF-1 versus 90%  4% for IGF-1 alone
(C and E) As controls, sister cultures were treated with an ODN in which the antisense sequence had been scrambled (C) or with an siRNA
that failed to reduce nuclear C/EBP levels (E). Left, without growth factor, support survival was modest. Right, NMDA treatment induced
nearly global death.
(F) In the absence of growth factor support, survival of neurons overexpressing a dominant-negative C/EBP is almost as high as in IGF-1-
treated untransfected neurons. Conversely, overexpressing wild-type C/EBP reduced survival. Open and closed bars, transfected and
untransfected neurons, respectively. Data are means  SEMs from 6 experiments. For transfectants, n/bar  500 neurons (range, 446–561).
For nontransfectants, n/bar  3100 neurons (range, 3008–3250). Asterisk, in nearly all cases, the survival of transfectants was significantly
different from untransfected neurons in the identical test condition (p  0.005).
(G) Specific block of C/EBP with either antisense ODN or siRNA strongly promotes survival and moderates NMDA-induced death. When
added, NMDA (300 M  1 M glycine) was present throughout the 1 day test period. Data are means  SEMs from 8 experiments. n/bar 
3700 neurons (range, 2834–4830). In all cases, the survival of antisense and siRNA transfectants was significantly higher than in the paired
control (p  0.005).
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Figure 5. Nuclear C/EBP Levels Rapidly Rise in the Absence of Growth Factor Support, while IGF-1 Keeps Them Low in an L Channel- and
CaMKIV-Dependent Manner
(A) IGF-1 keeps nuclear C/EBP levels low (a and c), requiring L channel (a1, b, and c) and CaMK (a1 and d) activities. (a) Cultured cerebellar
granule neurons were serum starved or treated with IGF-1 (50 ng/ml) for 1 hr, then lysed and the nuclear fractions were Western blotted for
C/EBP. Note that two bands of 40 kDa are often observed, although the lower band predominates (Pohnke et al., 1999; Piwien-Pilipuk et
al., 2001). (a1) IGF-1 stimulation maintains low nuclear levels of C/EBP (lane 2), but levels increase when growth factor support is removed
(lane 1) or when L channel or CaMK activities are inhibited (lanes 3 and 4); nimodipine, 5 M; KN62, 10 M. Conversely, NMDA receptor
activity increases the levels in a calcineurin-dependent manner: blocking NMDA receptors with 100 M APV reduces nuclear C/EBP (lane
5), stimulation with 300 M NMDA  1 M glycine increases it (lane 6), but when 1 M deltamethrin is coapplied, nuclear levels decline (lane
7). (a2) Concentration dependence: effectiveness increases dramatically as IGF-1 levels are increased (0 versus 0.5 to 500 ng/ml, 2 hr exposure).
(b) L channel dependence. Compared to neurons maintained in standard full serum medium or 4 hr in IGF-1 (left, center), blocking L channel
activity with 5 M nimodipine raises nuclear C/EBP levels (right). (c) Direct activation of L channels via depolarization (4 hr) in 25 mM KCl
also keeps nuclear levels low (upper), but concurrent L channel inhibition raises them (lower). (d) Assessed immunocytochemically, CaMKIV
activity leads to low nuclear C/EBP levels. (d1) Overexpressing a constitutively active CaMKIV reduces nuclear levels in serum-starved
neurons, although neighboring untransfected neurons display high levels. Paired panels show the same field, identifying transfectants (anti-
GFP) and C/EBP levels (anti-C/EBP, transfectants indicated by solid arrowheads). All immunocytochemistry experiments were performed
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indistinguishable from blocking AMPA receptors alone. activity and that the activity remains elevated for hours,
providing a potential explanation for how a brief stimulusHowever, blocking AMPA receptors with GYKI 52466 or
can exert long-lasting consequences. Consistent withlow concentrations of NBQX (5 M; Bureau et al., 1999)
studies showing that neuronal death induced by L chan-produced an intermediate level of survival that was no
nel block specifically involves caspase-3-dependentlonger sensitive to L channel blockade.
cleavage of CaMKIV (See et al., 2001), the effects weNeurons were also briefly exposed to IGF-1 in the
observe appear to be specific to CaMKIV. Survival waspresence of inhibitors (Figure 6B; “IGF-1”). As pre-
not maintained by constitutively active CaMKII, andviously shown (Blair et al., 1999), survival was high fol-
IGF-1 effects on CaMKII activity were relatively minor.lowing a 5 min IGF-1 stimulation (“IGF-1 alone”) but
Interestingly, however, we find that elevating the levelswere much lower when L channels were blocked by
of wild-type CaMKIV had little effect on survival at mod-nimodipine or Cd2during the IGF-1 stimulation. N chan-
erate-high levels of IGF-1, but a large effect at lowernel and sodium channel block, both of which should
IGF-1 concentrations or lower levels of L channel activ-reduce neurotransmission, exerted prosurvival effects
ity. Although altering CaMKIV levels cannot be consid-(“	-CgTx-GVIA,” “TTX”). Here, however, blocking NMDA
ered a natural situation, this result and the findings thatreceptors produced no significant increase in survival
antisense and siRNA to C/EBP can rescue neurons(“APV”), suggesting that their prodeath actions might be
from excitotoxic death suggest possible biomedical ap-compensated by growth factor support. Nonetheless,
plications.an L channel-dependent component was maintained
Multiple steps appear to be calcium dependent.(“APVnim”). Finally, AMPA receptor block again pro-
CaMKIV is indirectly calcium sensitive via CaM, but theduced intermediate levels of survival and occluded the
constitutively active CaMKIV that promoted survival waseffects of L channel block, implying that AMPA receptors
truncated to remove the autoinhibitory and CaM bindingare involved in both the prosurvival and prodeath path-
domains (Chatila et al., 1996), thereby eliminating theways. Moreover, our data indicate that L channel and
proximal requirement for calcium. Nevertheless, blockingNMDA receptor activities antagonistically compete to
L channel activity while expressing ca-CaMKIV de-control survival and support the thesis that the mode of
creased survival, indicating that basal levels of L channelcalcium entry is essential to determining the net effect:
activity may be sufficient for other calcium-requiringsurvival or death (Figure 7).
steps. Potential targets include CaMKK, which requires
CaM binding and phosphorylates CaMKIV to increase
Discussion its activity, and calcium-dependent transcription factors
such as CREB and MEF2, both of which are essential
IGF-1 is known to promote neuronal survival via CREB- for depolarization- and neurotrophin-mediated neuronal
mediated transcription (Brunet et al., 2001). Our data survival (Tao et al., 1998; Bonni et al., 1999; Hu et al.,
demonstrate that IGF-1 also acts through elevated L 1999; Mao et al., 1999; Rajadhyaksha et al., 1999;
channel-dependent calcium influx, resulting first in in- Blaeser et al., 2000; Mao and Wiedmann, 2000; Gong
creased CaMKIV activity and subsequently in reduced et al., 2003). Recent work further demonstrates that CaM
nuclear levels of the transcriptional activator C/EBP. binding to L channels is required for CREB activation
Conversely, NMDA receptor-mediated calcium influx in- (Dolmetsch et al., 2001), and that MEF2 is sensitive to
duces excitotoxic death, at least in part via the calcium- L channel-mediated calcium influx (Mao and Wiedmann,
dependent phosphatase calcineurin and strongly ele- 2000), with calcium and CaM relieving repression (Youn
vated nuclear C/EBP levels. et al., 2000).
Previously, we showed that IGF-1 improves neuronal Another family of transcription factors, the CCAAT
survival by potentiating L channel activity and that this enhancer binding proteins (C/EBPs), can be regulated
was surprisingly rapid: a 1 min exposure to IGF-1 pro- by CaMKIV activity (Yukawa et al., 1998). Typically,
moted survival in an L channel-dependent manner (Blair C/EBPs have been associated with survival in nonneu-
and Marshall, 1997; Blair et al., 1999). We now find that ronal cells (Buck et al., 2001; Zhu et al., 2002). In the
CaMKIV is an essential component of this pathway. We PC12 line, C/EBP activity is increased by NGF, a pro-
survival factor (Sterneck and Johnson, 1998), althoughalso determined that IGF-1 rapidly increases CaMKIV
a minimum of 6 times. (d2) In contrast, even though nuclear C/EBP levels are low in untransfected neurons in IGF-1, neurons overexpressing
dn-CaMKIV maintain high levels. (d3) Similarly, the general CaMK inhibitor, KN62 (10 M), fully blocks the ability of IGF-1 to maintain low
nuclear C/EBP levels.
(B) Nuclear C/EBP levels rise within 1 min of withdrawing growth factor support (lanes 1–4), but subsequent IGF-1 addition reduces them
(lanes 5–6).
(C) After 1 day in 0-serum, both antisense ODN and siRNA keep nuclear C/EBP levels low. Conversely, levels are high when neurons are
treated with either the scrambled antisense ODN or nonblocking siRNA, or maintained in the 0-serum vehicle.
(D) IGF-1 reverses serum deprivation- and NMDA-induced nuclear localization of C/EBP in a CRM1-dependent manner. Without growth
factor support (first panel, 3 h no IGF-1), nuclear C/EBP levels rise, but subsequent addition of IGF-1 reduces them (second panel, after 3
hr in 0-serum, 50 ng/ml IGF-1 was added for another 4 hr). When the nuclear transport protein CRM1 was blocked by treatment with leptomycin
B, nuclear levels remained high in IGF-1 (third panel, same as the second panel except that 20 ng/ml leptomycin B was added after the
second hour in 0-serum and was present during the subsequent IGF-1 exposure). Similarly, IGF-1 can at least partially reverse NMDA-induced
rises in nuclear C/EBP levels (fourth panel, see also Supplemental Figure S4) in a CRM1-dependent manner (fifth panel). Here, 300 M
NMDA  1 M glycine was added to 0-serum medium at the beginning of the experiment; otherwise, neurons were treated identically to
those in the second and third panels.
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Figure 6. NMDA and AMPA Receptors Exert Differential Effects on Neuronal Survival: NMDA Receptor Activity Promotes Death while AMPA
Receptors Appear to Play a Pivotal Role, Promoting Both L Channel-Mediated Survival and NMDA Receptor-Mediated Death
(A) L channel plus moderate AMPA activity strongly promote survival, and L channel agonists oppose NMDA receptor-induced death. First,
sister cultures of neurons were exposed to the L channel agonist, (-)-BayK8644 (0.8 M), and increasing concentrations of the AMPA receptor
agonist, kainate (0–100 M), for 24 hr. BayK8644 alone (“0 KA”) elevated survival over that in unsupplemented test medium (“No add”), but
coaddition of moderate concentrations of kainate (10 M, 30 M) strongly improved it; asterisk indicates survival significantly different from
BayK8644 alone (p  0.005, Student’s t test). In some cases, APV (100 M) or nimodipine (5 M) was also included to inhibit, respectively,
endogenous NMDA receptor or L channel activity: NMDA receptor block also improved survival relative to the same kainate concentrations
without APV (***p  0.005) and L channel block consistently reduced it (p  0.005). When neither BayK8644 nor APV were added, 10 M
kainate improved survival compared to “No add,” but coaddition of nimodipine decreased it, as did high (100 M) kainate. Alternatively, when
NMDA receptor activity was stimulated for 30 min with 300 M NMDA  1 M glycine, few neurons were alive after 1 day. However,
simultaneous exposure to 10 M kainate significantly ameliorated survival (**p  0.005, 15% versus 32%) in an L channel-dependent manner
(**p  0.005, 32% versus 14% when nimodipine was present). Again, coadding 100 M kainate with NMDA reduced survival to near zero,
but coadding 0.8 M BayK8644 improved it (, p  0.005 versus NMDA alone); this was partially diminished by inhibiting endogenous AMPA
receptor activity with 40 M CNQX (p  0.025). Values are means  SEMs. n/test combination  4500 neurons (range, 3040–6126) from 5
independent experiments.
(B) Pharmacological isolation of specific glutamate receptor subtypes. Sister cultures of neurons were maintained for 1 day in test media 
specific inhibitors (No IGF-1). Alternatively, neurons were first briefly exposed to IGF-1 (5 min, 50 ng/ml) in the presence of the inhibitors,
washed to remove IGF-1, and then maintained in the inhibitors for 1 day (IGF-1). Inhibitors, paired L channel block with 5 M nimodipine,
were: TTX, 1 M; APV, 100 M; GYKI 52466, 50 M; CNQX, 40 M; NBQX, 5 M, 100 M; and 	-conotoxin-GVIA, 400 nM (“	-CgTx-GVIA”).
(One exception: 100 M Cd2 was present only during the IGF-1-stimulation because extended N channel block was found to alter survival.)
Asterisk indicates when L channel block resulted in significantly lower survival (p  0.005); no difference was detectable between L channel
block by nimodipine or brief exposure to Cd2 (p  0.6). Summarized, NMDA receptor block (“APV,” “APVnim”) improved survival, which
still contained an L channel-dependent component, indicating that NMDA receptors do not stimulate L channel activity. In contrast, blocking
AMPA receptors (“GYKI,” “GYKInim,” and “5 M NBQX,” “5 M NBQXnim”) produced smaller overall effects on survival, but also eliminated
L channel dependence. This suggests that AMPA receptor activity stimulates both voltage-sensitive L channels (prosurvival) and NMDA
receptors (prodeath). Kainate receptors played no detectable role: blocking both AMPA and kainate receptors was indistinguishable from
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Figure 7. Glutamate Receptor Activity and IGF-1 Potentiation of Calcium Channel Subtypes May Perform Dual and Antagonistic Functions
Schema based on: (1) IGF-1 acts through PI3K, Akt, and src to potentiate neuronal L channel activity, and L channel potentiation promotes
survival (Blair and Marshall, 1997; Blair et al., 1999; Bence-Hanulec et al., 2000); (2) IGF-1 rapidly stimulates CaMKIV activity in an L channel-
dependent manner; (3) CaMKIV promotes survival; (4) IGF-1, L channel, and CaMKIV activities reduce nuclear C/EBP levels; (5) NMDA
receptor activity increases nuclear C/EBP levels and reduces survival, both being calcineurin dependent; (6) AMPA receptor activity stimulates
L channels to improve survival; and (7) AMPA receptors relieve Mg2 block of NMDA receptors (Nowak et al., 1984), thereby also contributing
to the NMDA receptor prodeath pathways. Narrow arrows indicate movement of signaling components between intracellular compartments.
it has been suggested that C/EBPmay be proapoptotic In cerebellar neurons, we find that nuclear C/EBP
levels are reduced by IGF-1 and L channel activity by ain Neuro2A cells (Cortes-Canteli et al., 2002). In neurons,
functions unrelated to survival were also recently de- process dependent upon CaMKIV and the nuclear ex-
port protein, CRM1. These results raise the possibilityscribed, with C/EBPbeing associated developmentally
with biasing cortical precursors to neurogenesis (Men- that CaMKIV may directly phosphorylate C/EBP to in-
duce its translocation. A potentially similar mechanismard et al., 2002) and, in mature animals, with long-term
memory (Taubenfeld et al., 2001a, 2001b). We predicted, regulates the prodeath Forkhead transcription factors
FOXO and AFX: Akt, which promotes survival by multiplebased on the prosurvival effect of C/EBPs on a variety
of cell types, that C/EBPwould act similarly in neurons. means including L channel potentiation (Blair et al.,
1999), negatively regulates FOXO by eliciting transloca-We found, however, that overexpressing dominant-neg-
ative C/EBP strongly elevated survival in the absence tion out of the nucleus (Brunet et al., 2001) and AFX by
preventing nuclear import (Brownawell et al., 2001). Weof IGF-1. To establish if the effect was specifically due
to C/EBP, we additionally tested if wild-type C/EBP also find that when nuclear levels decrease, C/EBP
is localized in large perinuclear puncta. Although thewas proapoptotic and if antisense oligonucleotides and
siRNA specific to C/EBPwere prosurvival. Finding that function of this distribution remains to be determined,
possibilities include that the protein is being held forall three approaches indicated that C/EBP might be
proapoptotic, we analyzed potential mechanisms. relocation back into the nucleus or is being targeted for
degradation. The first possibility is particularly attractiveRegulation of C/EBPs is complex. It is known that
they can act as either transcriptional enhancers or re- in light of our observation that, in a calcineurin-depen-
dent manner, nuclear C/EBP levels rapidly rise underpressors, that individual subtypes can heterodimerize
with other members, potentially altering DNA binding conditions that induce excitotoxic death.
Survival is a homeostatic process, but how neuronsspecificities or transactivating capabilities, and that for
C/EBP, dominant-negative isoforms occur naturally balance stimuli is not well understood. Our data suggest
that L channels and glutamate receptors perform antag-(Xiong et al., 2001). It is also known that C/EBPs contain
nuclear localization signals (NLS). In nonneural cells, onistic functions. IGF-1, direct L channel stimulation,
and blocking NMDA receptor activity all improve survivalTNF
 can induce rapid nuclear export of C/EBP via
phosphorylation of a specific serine residue within the and reduce nuclear C/EBP levels, while NMDA receptor
stimulation or blocking L channel activity decrease sur-NLS (Yin et al., 1996; Williams et al., 1997; Buck et al.,
2001). vival but increase nuclear C/EBP. We also find that N
blocking AMPA receptors alone. When sodium-dependent action potential activity was blocked (“TTX”), results roughly similar to NMDA
receptor block were obtained; note that any calcium-dependent action potentials (D’Angelo et al., 1997) would have been unaffected in TTX
alone. Likewise, blocking N channel activity (“	-CgTx-GVIA”), which would be expected to reduce neurotransmission, increased survival, but
L channel activity was still required to maximize it (“	-CgTx-GVIAnim”). Values are means  SEMs. n/test combination  3000 neurons
(range, 1846–4509) from 3 independent experiments.
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channel blockade, which would be predicted to reduce lating IRS-1, the docking protein mediating IGF-1 recep-
tor responses (Hallak et al., 2001).neurotransmission, reduces nuclear levels and pro-
motes survival, implying that IGF-1, which potentiates C/EBP appears to be another pivot point. We show
here that both the excitotoxic and L channel pathwaysN as well as L channel activity (Blair and Marshall, 1997),
may serve a more complicated role than simply acting regulate its subcellular localization. IGF-1 potentiation
of L channels acts through CaMKIV to promote survivalas a survival factor. Moreover, given that NMDA recep-
tors also mediate calcium influx, it is especially striking by reducing nuclear C/EBP levels, and NMDA receptor
activity acts antagonistically through calcineurin to in-that the mode of calcium entry differentially regulates
survival processes. L channel activity and IGF-1 stimu- crease them.
late CREB phosphorylation and activity (Rajadhyaksha
Experimental Procedureset al., 1999), while extrasynaptic NMDA receptor activity
leads to CREB dephosphorylation (Sala et al., 2000;
Cell Culture
Hardingham et al., 2002). Our results also imply differen- Cerebellar granule neurons were cultured from P5–P6 rats (Blair et
tial synaptic effects: moderate levels of AMPA receptor al., 2001). Standard medium was DMEM with 10% fetal bovine serum
activity appear to stimulate L channels to improve sur- (GIBCO-BRL), penicillin/streptomycin, 20 M fluorodeoxyuridine to
arrest division of nonneuronal cells, 25 mM KCl, and 6 g/l glucose.vival, whereas higher levels predominantly act to stimu-
Test media were without serum and contained 5 mM KCl.late NMDA receptor-mediated death. The concept that
the conditions of activation are important is underscored
Expression Vectors and Neuronal Transfection
by the multiple functions of NMDA receptors, L chan- Granule neurons were transfected with full-length wild-type C/EBP;
nels, and C/EBP: all are involved in learning and mem- dominant-negative C/EBP (Olive et al., 1996); wild-type, catalytically
ory as well as cellular survival. inactive, or constitutively active CaMKIV (Chatila et al., 1996); consti-
tutively active CaMKK; or constitutively active CaMKII (Sun et al.,Mechanisms underlying differential calcium signaling
1994). Note that the dn-CaMKIV is unlikely to act nonspecifically: itare likely to involve subcellular compartmentalization of
was rendered catalytically inactive by a single-point mutationintermediates. Studies have demonstrated that L chan-
(K75E), making it almost identical to wt-CaMKIV. All cDNAs were in
nel activity need not increase bulk cytosolic calcium to pSG5 expression vectors (Stratagene). Neurons, 2–3 days in culture,
induce transcription and imply that the initial step may were cotransfected in 2 ml media with 0.5–1 g of the cDNA of
be rapid coupling of incoming calcium to calcium bind- interest or plus 0.5 g SuperGlo-GFP cDNA (Quantum Biotechnolo-
gies) to identify transfectants (Blair et al., 1999, 2001).ing proteins closely associated with the channel (Deis-
seroth et al., 1996, 1998). CaM is known to bind to L
Oligodeoxynucleotide, siRNA, and Transfectionchannels (Peterson et al., 1999) and to be capable of
An antisense C/EBP ODN [CCA GCA GGC GGT GCA TGA AC]nuclear translocation (Deisseroth et al., 1998; Wang et directed against the extreme 5 end and the first in-frame AUG of
al., 2000; Mermelstein et al., 2001). Interestingly, L chan- the rat C/EBP- transcript (Taubenfeld et al., 2001a) was synthe-
nel potentiation is greatest at moderately hyperpolarized sized (Life Technologies). Scrambled antisense C/EBP [TCG GAG
ACT AAG CGC GGC AC] served as control and was of identicalpotentials (e.g., 40 mV; Blair and Marshall, 1997;
length, containing in scrambled form the same A/T C/G composition;Bence-Hanulec et al., 2000), and activating L channels
it also showed no homology to any sequence in the GenBank data-via excitatory postsynaptic potentials (i.e., moderately
base. ODNs had phosphorothioate linkage on the three terminalhyperpolarized potentials) is more effective than action bases of the 5 and 3 ends and phosphodiester internal bonds
potentials for promoting CREB phosphorylation (Mer- because such ODNs retain biochemical specificity, are more stable
melstein et al., 2000). than the unmodified phosphodiester ODNs in vivo, and are less
toxic than the full phosphorothioate ODNs (Ogawa and Pfaff, 1998).Although compartmentalization offers a means for
ODN transfection was performed according to manufacturer’s in-separating calcium-dependent survival and death
structions using Oligofectamine reagents (Life Technologies); finalmechanisms, extensive possibilities for crosstalk also
concentrations were 300–400 nM. Efficiency was assessed after 1exist. Our data, summarized in Figure 7, suggest that day in serum-free medium (Figure 5C, Supplemental Figure S5 at
CaMKIV may be a shared target of the pro- and antiapo- http://www.neuron.org/cgi/content/full/39/4/625/DC1).
ptotic pathways. Calcineurin can deactivate CaMKIV C/EBP siRNA [AAG CTG AGC GAC GAG TAC AAG] and non-
blocking sequence [AAG TGG CCA ACT TCT ACT ACG] were de-(Enslen et al., 1994) and calpain cleaves it (McGinnis et
signed according to manufacturer’s recommendations (Quiagen-al., 1998). Interestingly, the role(s) of calcineurin are not
Xeragon). The blocking sequence has no homology to any other inentirely clear. We and others find that inhibition of cal-
the GenBank database. Transfections were performed per manufac-
cineurin promotes neuronal survival and opposes exci- turer’s instructions (Quiagen-Xeragon) and efficiency assessed after
totoxicity (Dawson et al., 1993; Ankarcrona et al., 1996; 1 day (Figure 5C).
McDonald et al., 1996; Wang et al., 1999; Ruiz et al.,
Survival Assays2000). However, under some conditions, NMDA receptor
Neurons were cultured in standard medium for 2 days, then rinsed,activity promotes survival, a disparity that may be due
subjected to manipulation, and grown in test media for 1 day (Blairto activating extrasynaptic versus synaptic receptors
et al., 1999). Primary media were: test medium (0-serum with 5 mM
(Sinor et al., 2000; Hardingham et al., 2002). Calcineurin KCl), or test medium with 50 ng/ml IGF-1 with or without the L
has also been reported both to reduce and enhance the channel inhibitor, nimodipine. For each experiment, test media were
activity of neuronal L channels (Hernandez-Lopez et al., assayed in quadruplicate on sister cultures.
For transient pharmacological inhibition of CaMKs, the general2000; Norris et al., 2002), and it can control prosurvival
CaMK inhibitor KN62 was employed at a concentration (10 M)transcription factors, increasing the activity of MEF2
where it is known to block CaMKIV (Enslen et al., 1994). Prior to(Mao and Wiedmann, 2000) and inducing nuclear import
exposure to IGF-1, neurons were pretreated for 15 min with KN62
of NFAT (Crabtree and Olson, 2002). Conversely, cal- or its vehicle (0.1% DMSO), then briefly stimulated with IGF-1 (50
cineurin activated by NMDA receptors may negatively ng/ml for 1 min) in the presence of inhibitor or vehicle. IGF-1 was
then removed by washing 3 in basic test medium (complete bathregulate the IGF-1 survival pathways by dephosphory-
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exchange), and KN62 or vehicle was readded for an additional 2 hr. observed in full serum as 1.0 and expressing the experimental values
as fold-change. When the reference was serum-starved neurons,Neurons were washed again to remove inhibitor and replaced in
basic test medium for another 22 hr. values were calculated as percentage-change relative to that ob-
served in 0-serum (100%).To determine apoptosis, the primary assays were: propidium io-
dide (PI) labeling to reveal condensation state of the chromatin and
the TUNEL assay to reveal chromatin cleavage; in some cases, the Immunocytochemistry
nuclear stain DAPI (500 nM) was employed. For PI labeling, cells Cells were fixed in 1.5% PFA, permeabilized in 0.1% Triton X-100
were fixed (1.5% PFA) and permeabilized with 0.1% Triton X-100, and, following block of nonspecific sites in 4% goat serum (Gemini
and the chromatin was stained with 2 g/ml PI. Neurons were Bio-Products), labeled for indirect immunofluorescence. Primary an-
counted “blind” on a Zeiss Axioskop equipped for epifluorescence tibodies were anti-C/EBP (rabbit polyclonal sc-150, Santa Cruz
using rhodamine optics to visualize the PI and GFP filter settings Biotechnology, 1:1000 dilution), anti-FLAG epitope (M2 mouse
to identify transfectants. All transfected neurons in a culture were monoclonal anti-FLAG, Sigma, 2 g/ml), anti-pCREB (rabbit poly-
counted; for nontransfectants, all neurons in four randomly chosen clonal #06-519, Upstate Biotechnology, 1:500), Tuj1 (Covance Re-
fields were assessed. The survival of transfectants was then com- search Products #MMS-435P, 1:500), and anti-GFP (rabbit poly-
pared to nontransfectants within each culture; comparison within clonal “living color peptide Ab,” Clontech, 1:50, or mouse
cultures ensures that all neurons will be handled identically and that monoclonal #AFP5002, Q-Biogene, 1:100). Secondary antibodies
the sole difference will be whether a neuron is overexpressing the were anti-mouse IgG-FITC (#115-095-071, Jackson ImmunoRe-
exogenous gene products. For the TUNEL assay, fixed cultures were search Lab, 1:600), anti-mouse IgG-rhodamine (#115-295-116, Jack-
exposed to a 1:2 solution of ethanol:acetic acid to quench GFP son ImmunoResearch Lab, 1:100), and anti-rabbit IgG-rhodamine
fluorescence and processed as per manufacturer’s instructions us- Red-X (#111-295-144, Jackson ImmunoResearch Lab, 1:100). Neu-
ing the In Situ Cell Death Detection kit (Boehringer Mannheim). GFP- rons were visualized on a Zeiss Axiovert 100 laser scanning confocal
containing neurons were then identified by indirect immunolabeling microscope or a Zeiss Axioskop equipped for epifluorescence.
using a rhodamine-conjugated secondary. Labeled (i.e., cleaved)
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